Align Technology (ALGN) Short Thesis 2016 – McAndrews

Investment thesis arguing for a short position on Align Technology (ALGN) based on unsustainable growth guidance, patent erosion, and declining market share. The thesis targets a $45 price (43% downside) versus consensus of $74, citing premium valuation relative to fundamentals and catalysts including anticipated sales misses and stock re-rating.